 |
市場調查報告書
商品編碼
1638765
2024年至2032年獸用抗感染藥市場機會、成長動力、產業趨勢分析與預測Veterinary Anti-infectives Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
||||||
2023年全球獸用抗感染藥市場價值為54億美元，預計2024年至2032年複合年成長率為3.5%。抗感染治療對於控制細菌、病毒和真菌感染、預防可能導致農業重大經濟損失的潛在疾病爆發至關重要。此外，它們還有助於改善伴侶動物的整體福祉，促進該行業對有效治療的需求不斷成長。
根據動物類型，市場分為兩個部分：牲畜和伴侶動物。預計畜牧業將繼續佔據主導地位，在 2023 年佔據最大的收入佔有率，並預計在整個預測期內以 3.4% 的成長率保持領先地位。這種主導地位是由大規模農業經營中疾病管理和預防的需求所驅動的。全球肉類需求的成長以及動物健康意識的提高，進一步推動了牲畜管理中抗感染解決方案的採用。
獸用抗感染藥市場依產品類型進一步分類，包括抗菌藥、抗黴菌藥、抗病毒藥和抗寄生蟲藥。其中，抗菌領域佔有最大的市場佔有率，2023年將佔44.3%，預計仍將維持領先地位。這是因為抗生素在解決牲畜和伴侶動物的細菌感染方面發揮關鍵作用。細菌性疾病的日益普及以及抗生素抗藥性帶來的持續挑戰凸顯了持續創新和研究開發抗菌治療的重要性。
| 市場範圍 | |
|---|---|
| 開始年份 | 2023年 |
| 預測年份 | 2024-2032 |
| 起始值 | 54億美元 |
| 預測值 | 74 億美元 |
| 複合年成長率 | 3.5% |
在北美，獸用抗感染藥物市場可望大幅成長，其中美國到2023年將貢獻20億美元。美國也受益於嚴格的監管框架，確保抗感染產品的安全性和有效性，進一步鼓勵產業成長。寵物擁有量的增加和對畜產品的需求不斷成長，繼續推動對獸用抗感染藥物的需求，使美國成為全球市場的關鍵參與者。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 動物中人畜共通傳染病的發生率上升
- 獸藥不斷進步
- 對肉類和動物產品的需求不斷增加
- 政府不斷採取措施控制動物疾病
- 產業陷阱與挑戰
- 對抗生素抗藥性的擔憂日益加劇
- 嚴格的監管挑戰
- 成長動力
- 成長潛力分析
- 監管環境
- 管道分析
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 公司矩陣分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按動物類型，2021 - 2032
- 主要趨勢
- 畜牧動物
- 牛
- 家禽
- 豬
- 其他家畜動物
- 伴侶動物
- 狗
- 貓
- 其他伴侶動物
第 6 章：市場估計與預測：按產品類型，2021 - 2032 年
- 主要趨勢
- 抗菌
- 抗真菌劑
- 抗病毒藥
- 抗寄生蟲藥
第 7 章：市場估計與預測：按管理途徑，2021 - 2032 年
- 主要趨勢
- 口服
- 注射用
- 專題
- 其他給藥途徑
第 8 章：市場估計與預測：按配銷通路，2021 - 2032 年
- 主要趨勢
- 零售藥局
- 網路藥局
- 獸醫院藥房
第 9 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
第 10 章：公司簡介
- Aspen Veterinary Resources
- Boehringer Ingelheim International
- Ceva
- Dechra Pharmaceuticals
- Elanco
- Merck & Co
- Norbrook
- Phibro Animal Health
- Vetoquinol SA
- Virbac
- Zoetis
The Global Veterinary Anti-infectives Market, valued at USD 5.4 billion in 2023, is expected to expand at a CAGR of 3.5% from 2024 to 2032. This growth is driven by the rising prevalence of infectious diseases in livestock and companion animals. Anti-infective treatments are essential for managing bacterial, viral, and fungal infections, preventing potential disease outbreaks that can result in significant economic losses in agriculture. Additionally, they help improve the overall well-being of companion animals, contributing to the growing demand for effective treatments in the sector.
The market is divided into two segments based on animal type: livestock and companion animals. The livestock segment is anticipated to remain dominant, holding the largest revenue share in 2023, and is projected to maintain its leadership throughout the forecast period with a growth rate of 3.4%. This dominance is driven by the need for disease management and prevention in large-scale farming operations. Rising global demand for meat, along with increased awareness of animal health, further propels the adoption of anti-infective solutions in livestock management.
The veterinary anti-infectives market is further categorized by product type, including antibacterial, antifungal, antivirals, and antiparasitics. Among these, the antibacterial segment holds the largest market share, accounting for 44.3% in 2023, and is expected to remain the leading category. This is due to the critical role antibiotics play in addressing bacterial infections in both livestock and companion animals. The growing prevalence of bacterial diseases and the ongoing challenges posed by antibiotic resistance highlight the importance of continuous innovation and research in developing antibacterial treatments.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $5.4 Billion |
| Forecast Value | $7.4 Billion |
| CAGR | 3.5% |
In North America, the veterinary anti-infectives market is poised for significant growth, with the U.S. contributing USD 2 billion in 2023. Factors such as a well-established healthcare infrastructure, heavy investment in research and development, and a high incidence of infectious diseases in humans and animals support the market's expansion. The U.S. also benefits from a strict regulatory framework that ensures the safety and efficacy of anti-infective products, further encouraging industry growth. Increasing pet ownership and rising demand for livestock products continue to drive the need for veterinary anti-infectives, making the U.S. a key player in the global market.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of zoonotic diseases among animals
- 3.2.1.2 Growing advancements in veterinary medicines
- 3.2.1.3 Increasing demand for meat and animal products
- 3.2.1.4 Growing government initiatives to control animal diseases
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Rising concerns over antibiotic resistance
- 3.2.2.2 Stringent regulatory challenges
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Pipeline analysis
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Livestock animals
- 5.2.1 Cattle
- 5.2.2 Poultry
- 5.2.3 Swine
- 5.2.4 Other livestock animals
- 5.3 Companion animals
- 5.3.1 Dogs
- 5.3.2 Cats
- 5.3.3 Other companion animals
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Antibacterial
- 6.3 Antifungal
- 6.4 Antivirals
- 6.5 Antiparasitics
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Oral
- 7.3 Parenteral
- 7.4 Topical
- 7.5 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Retail pharmacies
- 8.3 Online pharmacies
- 8.4 Veterinary hospital pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
Chapter 10 Company Profiles
- 10.1 Aspen Veterinary Resources
- 10.2 Boehringer Ingelheim International
- 10.3 Ceva
- 10.4 Dechra Pharmaceuticals
- 10.5 Elanco
- 10.6 Merck & Co
- 10.7 Norbrook
- 10.8 Phibro Animal Health
- 10.9 Vetoquinol S.A.
- 10.10 Virbac
- 10.11 Zoetis
